J 2016

Clonal cytogenetics changes in progression of multiple myeloma to extramedullary relapse and plasmocellular leukemia: a case report

SMETANA, Jan, Petr KUGLÍK, Henrieta GREŠLIKOVÁ, Renata KUPSKÁ, Pavel NĚMEC et. al.

Basic information

Original name

Clonal cytogenetics changes in progression of multiple myeloma to extramedullary relapse and plasmocellular leukemia: a case report

Authors

SMETANA, Jan (203 Czech Republic, guarantor, belonging to the institution), Petr KUGLÍK (203 Czech Republic, belonging to the institution), Henrieta GREŠLIKOVÁ (703 Slovakia, belonging to the institution), Renata KUPSKÁ (203 Czech Republic, belonging to the institution), Pavel NĚMEC (203 Czech Republic, belonging to the institution), Aneta MIKULÁŠOVÁ (203 Czech Republic, belonging to the institution), Iveta VALÁŠKOVÁ (203 Czech Republic), Jan OPPELT (203 Czech Republic, belonging to the institution), Martina ALMÁŠI (203 Czech Republic, belonging to the institution), Marta KREJČÍ (203 Czech Republic), Zdeněk ADAM (203 Czech Republic), Luděk POUR (203 Czech Republic) and Roman HÁJEK (203 Czech Republic, belonging to the institution)

Edition

International Journal of Clinical and Experimental Pathology, USA, e-Century Publishing Corporation, Madiso, 2016, 1936-2625

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

Genetics and molecular biology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.706

RIV identification code

RIV/00216224:14310/16:00088866

Organization unit

Faculty of Science

UT WoS

000371354200006

Keywords in English

Multiple myeloma; extramedullary relapse; clonal evolution; genetic changes; ploidy switch; TP53 mutations

Tags

Tags

International impact, Reviewed
Změněno: 26/4/2017 22:00, Ing. Andrea Mikešková

Abstract

V originále

Extramedullary relapse (EM) is an aggressive form of the disease with a dismal outcome. We present cytogenetic findings of a 52-year-old female with MM, which progressed rapidly into plasmocellular leukemia and extramedullary subcutaneous tumor in the head. At the time of diagnosis, G-banding showed hypotriploid karyotype (63-64 chromosomes) and using cIg-FISH we found translocation t(4;14)(p16;q32) and gain(1)(q21). At the time of disease progression, the same chromosomal abnormalities were present in the bone marrow, peripheral blood and the EM lesion: del(13)(q14), del(17)(p13), t(4;14)(p16;q32) and gain(1)(q21). Before progression, array-CGH showed, hyperdiploid karyotype with trisomies of chromosomes 2, 3, 7, 8, 9, 11, 17, 18, 19 and 20, while after progression non-hyperdiploid karyotype was detected with additional structural deletions in 1p, 2p, 4q, 11p, 12p, 13, 14q, 17p, 22q and homozygous deletion in 1p32.3. In addition, deep resequencing of TP53 showed presence of 2 known mutations in exon 6(c.632C>T) and exon 7(c.700T>C). In summary, EM relapse of this patient was connected to a change of the entire genome profile. Extramedullary lesion most probably originated by an expansion of one clone of tumor plasma cells from the bone marrow, which was confirmed by identical genomic profile of both tested samples. Thus, change of ploidy status should be considered as potential hallmark of adverse course of the disease.

Links

EE2.3.20.0183, research and development project
Name: Centrum experimentální biomedicíny
NT13492, research and development project
Name: Úloha genetických abnormalit ve vývoji a progresi prekancerózy monoklonální gamapatie nejasného významu